Literature DB >> 30787466

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.

Andrew Lee1, Nasim Mavaddat1, Amber N Wilcox2, Alex P Cunningham1, Tim Carver1, Simon Hartley1, Chantal Babb de Villiers3, Angel Izquierdo4, Jacques Simard5, Marjanka K Schmidt6, Fiona M Walter3, Nilanjan Chatterjee7,8, Montserrat Garcia-Closas2, Marc Tischkowitz9, Paul Pharoah1,10, Douglas F Easton1,10, Antonis C Antoniou11.   

Abstract

This has now been corrected in both the PDF and HTML versions of the Article. The authors regret this error.

Entities:  

Year:  2019        PMID： 30787466      PMCID： PMC7608223          DOI： 10.1038/s41436-019-0459-4

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


Correction to: Genetics in Medicine 10.1038/s41436-018-0406-9; published online 15 January 2019 The original version of this article contained a typographical error in Eq. 2. The summation in the equation should run up to , and so Eq. 2 should have readwhere corresponds to a noncarrier of pathogenic variants in the major genes, with , and for noncarriers of pathogenic variants, and 0 otherwise. All presented results and conclusions were based on the correct version of the equation and are not influenced by this typographical error. This has now been corrected in both the PDF and HTML versions of the Article. The authors regret this error.
  7 in total

1.  Choosing Breast Cancer Risk Models: Importance of Independent Validation.

Authors:  Mitchel H Gail
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

2.  Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.

Authors:  Amber N Hurson; Parichoy Pal Choudhury; Chi Gao; Anika Hüsing; Mikael Eriksson; Min Shi; Michael E Jones; D Gareth R Evans; Roger L Milne; Mia M Gaudet; Celine M Vachon; Daniel I Chasman; Douglas F Easton; Marjanka K Schmidt; Peter Kraft; Montserrat Garcia-Closas; Nilanjan Chatterjee
Journal:  Int J Epidemiol       Date:  2021-03-23       Impact factor: 9.685

3.  Headaches and polygenic scores.

Authors:  Bjarni J Vilhjálmsson; Florian Privé
Journal:  Neurol Genet       Date:  2019-10-24

4.  BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome.

Authors:  Trong-Nhan N Le; Van-Khanh Tran; Thu-Thuy Nguyen; Nam S Vo; Tham H Hoang; Hoang-Long Vo; Thanh-Hai T Nguyen; Phuoc-Dung Nguyen; Viet-Tien Nguyen; Thanh-Van Ta; Huy-Thinh Tran
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

5.  Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study.

Authors:  Anne Brédart; Antoine De Pauw; Anja Tüchler; Inge M M Lakeman; Amélie Anota; Kerstin Rhiem; Rita Schmutzler; Christi J van Asperen; Peter Devilee; Dominique Stoppa-Lyonnet; Jean-Luc Kop; Sylvie Dolbeault
Journal:  Clin Genet       Date:  2022-05-16       Impact factor: 4.296

6.  Gene-based and pathway-based testing for rare-variant association in affected sib pairs.

Authors:  Razvan G Romanescu; Jessica Green; Irene L Andrulis; Shelley B Bull
Journal:  Genet Epidemiol       Date:  2020-04-01       Impact factor: 2.135

Review 7.  Validity of polygenic risk scores: are we measuring what we think we are?

Authors:  A Cecile J W Janssens
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.